121 related articles for article (PubMed ID: 37725571)
21. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
[TBL] [Abstract][Full Text] [Related]
22. Is radioiodine ablation with 1.1 GBq (30 mCi)
Ilera V; Califano I; Cavallo A; Faure E; Vázquez A; Pitoia F;
Endocrine; 2023 Jun; 80(3):606-611. PubMed ID: 36988853
[TBL] [Abstract][Full Text] [Related]
23. Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine.
Ajdari SE; Shafiei B; Motazedian M; Qutbi M; Esmaeilzadeh P; Asli IN; Javadi H; Assadi M
Nuklearmedizin; 2019 Jun; 58(3):249-257. PubMed ID: 31060081
[TBL] [Abstract][Full Text] [Related]
24. IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?
Lamartina L; Montesano T; Falcone R; Biffoni M; Grani G; Maranghi M; Ciotti L; Giacomelli L; Ramundo V; Lomonaco C; Di Gioia CR; Piernatale L; Ronga G; Durante C
Endocr Pract; 2019 Feb; 25(2):165-169. PubMed ID: 30383494
[TBL] [Abstract][Full Text] [Related]
25. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
[TBL] [Abstract][Full Text] [Related]
26. Coexistence of Hashimoto's Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response.
Donnici A; Mirabelli M; Giuliano S; Misiti R; Tocci V; Greco M; Aiello V; Brunetti FS; Chiefari E; Aversa A; Foti DP; Brunetti A
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248043
[TBL] [Abstract][Full Text] [Related]
27. Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up study.
Rotondi M; Groppelli G; Croce L; Latrofa F; Ancona G; Coperchini F; Pasquali D; Cappelli C; Fugazza A; Guazzoni V; Radetti G; Chiovato L
Eur J Endocrinol; 2020 Sep; 183(3):317-323. PubMed ID: 32717718
[TBL] [Abstract][Full Text] [Related]
28. Benign and malignant thyroid nodules with autoimmune thyroiditis.
Kassi GN; Evangelopoulou CC; Papapostolou KD; Karga HJ
Arch Endocrinol Metab; 2022 Sept 08; 66(4):446-451. PubMed ID: 35657125
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma - a follow-up study.
Januś D; Kujdowicz M; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Górecki W; Starzyk JB
Front Endocrinol (Lausanne); 2023; 14():1172823. PubMed ID: 37124746
[TBL] [Abstract][Full Text] [Related]
30. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
[TBL] [Abstract][Full Text] [Related]
31. Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma.
Morosán YJ; Parisi C; Urrutia MA; Rosmarin M; Schnitman M; Serrano L; Luciani W; Faingold C; Pitoia F; Brenta G
Arch Endocrinol Metab; 2016 Aug; 60(4):348-54. PubMed ID: 26910621
[TBL] [Abstract][Full Text] [Related]
32. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
Liu YQ; Li H; Liu JR; Lin YS
Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
[No Abstract] [Full Text] [Related]
33. Higher TSH Is Not Associated With Thyroid Cancer Risk in the Presence of Thyroid Autoimmunity.
Paparodis RD; Bantouna D; Karvounis E; Imam S; Jaume JC
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32391913
[TBL] [Abstract][Full Text] [Related]
34. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.
Redlich A; Luster M; Lorenz K; Lessel L; Rohrer TR; Schmid KW; Frühwald MC; Vorwerk P; Kuhlen M
J Clin Endocrinol Metab; 2022 Jan; 107(1):e165-e177. PubMed ID: 34415989
[TBL] [Abstract][Full Text] [Related]
35. Superiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablation.
Hong CM; Lee WK; Jeong SY; Lee SW; Ahn BC; Lee J
Nucl Med Commun; 2014 Nov; 35(11):1119-26. PubMed ID: 25144561
[TBL] [Abstract][Full Text] [Related]
36. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.
Pitoia F; Jerkovich F; Urciuoli C; Schmidt A; Abelleira E; Bueno F; Cross G; Tuttle RM
Thyroid; 2015 Nov; 25(11):1235-42. PubMed ID: 26132983
[TBL] [Abstract][Full Text] [Related]
37. Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients: Is Thyroglobulin Stimulation Required?
Moreno I; Hirsch D; Duskin-Bitan H; Dicker-Cohen T; Shimon I; Robenshtok E
Thyroid; 2020 Jun; 30(6):863-870. PubMed ID: 31928205
[No Abstract] [Full Text] [Related]
38. Radioiodine versus no radioiodine outcomes in low-risk differentiated thyroid cancers: A propensity-score matched analysis.
Satapathy S; Tupalli A; Chandekar KR; Ballal S; Bal C
Clin Endocrinol (Oxf); 2023 Nov; 99(5):483-491. PubMed ID: 37491776
[TBL] [Abstract][Full Text] [Related]
39. Differentiated Thyroid Cancers in Young Adults Versus Children: Clinical Characteristics and 10-year Follow-up Outcomes.
Satapathy S; Majeed AK; Ballal S; Bal C
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1670-e1677. PubMed ID: 37285485
[TBL] [Abstract][Full Text] [Related]
40. Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study.
Zuhur SS; Aggul H; Çelik M; Avci U; Erol S; Kilinç F; Akbaba G; Cinar N; Tekin S; Sahin S; Bilen O; Elbuken G; Guldiken S; Kadioglu P; Bayraktaroglu T; Topcu B; Altuntas Y
Endocr Pract; 2022 Jan; 28(1):30-35. PubMed ID: 34508902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
